Theragen Bio | Global genome service provider and AI-based biopharmaceutical company

PR Center

Press Release

: 2022-07-22

[Press Release]Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency.

: 2022-07-19

[Press Release]Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature

: 2022-07-13

[Press Release]Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development.

: 2022-06-07

[Press Release]Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency.

: 2022-04-21

[Press Release]Theragen Bio, designated as a clinical trial specimen analysis institution by the Ministry of Food and Drug Safety

: 2022-04-19

[etnews] "Genetics is based on innovation in the bio industry..."No regulatory frames in DTC

: 2022-04-13

[Korea Biomedical Review] Theragen Bio starts upgraded disease-predicting personal genetic testing

: 2022-04-13

[Press Release]Theragen Bio to launch HelloGene 4.0, a disease prediction genetic test

: 2022-04-07

[Press Release]Theragen Bio to acquire a patent of AI-Based Patient Classification Molecular Subtype Calculation Device, DeepOmics Marker™

: 2020-07-31

[Bloomberg]THERAGEN BIO ANALYZES LARGEST COVID-19 PATIENT DATA IN KOREA

: 2020-03-08

[The Korea Herald]‘ALL CONSUMER DECISIONS TO SOON DEPEND ON GENOMIC DATA’

: 2019-08-07

[Korea Times] 'GENETIC TESTING WILL LEAD TO NEW BUSINESSES'

1
2

List